Relation Hepcidin with Renal Failure
DOI:
https://doi.org/10.46966/msjar.v1i01.9Keywords:
Renal Failure, glomerular filtration rate (GFR), HepcidinAbstract
Renal failure refers to a condition where the kidneys lose their normal functionality, which may be due to various factors including infections, auto immune diseases, diabetes and other endocrine disorders, cancer, and toxic chemicals. It is characterized by the reduction in the excretory and regulatory functions of kidney. Biochemically, it is typically detected by an elevated serum creatinine. In the science of physiology it is described as a decrease in glomerular filtration rate (GFR). Hepcidin is a peptide produced primarily in the liver. Its mature form consists of 25 amino acids with a calculated mass of 2.8 kDa . Hepcidin has a key role in iron homeostasis by interacting with ferroportin. Hepcidin is the regulator of iron homeostasis in humans and other mammals. In humans, HAMP is the gene that encodes for hepcidin. 25-amino acid peptide was first identified in human urine and plasma. This peptide contains four disulfide bonds. It is synthesized, processed and secreted primarily by hepatocytes. In vitro, human hepcidin has anti-bacterial and antifungal activities. The 25-amino acid peptide of hepcidin is secreted by the liver, which seems to be the "master regulator" of iron metabolism.
References
Al-Fahham,A.A.(2011) A Study of Som Physiological and Biochemichal Changes in Patients With Cronic Renal Failure Undergoing Hemodialysis in Al-Najaf Governorate.(Master Thesis).
Ashby, D.R.; Gale, D.P and Busbridge, M . (2009). Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease". Kidney Int., 75: 976–81.
Babitt, J.L.; Lin, H.Y. (2010) Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD. AmJKidney Dis. , 55: 726-741.
Besarab, A.; Coyne, D.W. (2010) .Iron supplementation to treat anemia in patients with chronic kidney disease. Nat Rev Nephrol., 6: 699-710. Blood., 99:3505–3516.
Boon , N.; Colledge, N.R.; and Walker, B. R. (2006). Davidsons principles and practice .20th Ed Churchill Livingstone, Philadelphia, USA.
Brady, H. R .;Singer, G.G. (1995). Acute renal failure . Lancet; 346:1533- 40.
Burrows, N.R.; Hora, I.; Chso, Gerzoff, R.B. and Geiss, L.S.(2010).Incidence of end stage Renal disease Attributed to Diabetes Among Person With Diagnosed Diabetes-United States and Puerto Rico ,1996-2007. JAMA ., 304:2688-90.
Chhetri, P.K.; Manandhar, D.N.; Bhattarai, S.P.; Pahari , L.R . and Shrestha, R. (2008). Chronic Kidney Disease 5on Hemodialysis in Nepal Medical College. Nepal Med COLL J., 10:8-10.
Collins, A.J .;Kasiske, B. ;Herzog ,C. (2003). Excerpts from the United States Renal Data System .Annual data report : atlas of end-stage renal disease in the United States .Am J Kidney Dis;42 (6 suppl 5):S1-S226.
Coyne, D.W. (2011) . Hepcidin: clinical utility as a diagnostic tool and therapeutic target. Kidney Int., 80: 240-244.
Davidson, A.M. ; Cameron, J.S.; and Ypersele , C.V. (2005) . Oxford Textbook of Clinical Nephrology. 3rd ed Oxford university Press Inc, New York, USA.
DiGiulio , M .Jackson , and Keogh, J. (2007). Medical-surgical nursing: demystified .McGraw-Hill Companies, Inc, USA.
Eschbach, J.W. ; Cook, J.D.; Scribner, B.H. et al. (1977). Iron balance in hemodialysis patients. Ann Intern Med.,87: 710-713.
Feest, T.G.; Round, A.; Hamad, S. (1993). Incidence of sever acute renal failure in adults results of community based study . BMJ ., 306 :481-3.
Finn, W.F. (1993). Recovery from acute renal failure in. Lazarus JM , Brenner BM ,eds. Acute renal failure . 3d Ed. New York : Churchill Livingstone ., 553 -96.
Ganz ,T .(2003). Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102 (3): 783–8.
Guyton ,A.C. and Hall, J.E. (2006) .Textbook of medical physiology . 11th Ed. Elsevier Saunders . Philadelphia , USA.
Guyton, A.C. and Hall, J.E. (2011). Textbook of Medical Physiology, 12th Edition, Saunders, Philadelphia, USA.
Herzog, C., Asinger, R., Berger, A., Charytan, D., D ez J., Hart, R., Eckardt , K., Kasiske, B., McCullough, P., Passman, R., DeLoach, S., Pun, P., and Ritz, E. 2011. Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). International Society of Nephrology. 1038(10): 223-30
Jolanta, M.; Jacek, S. ;Malyszko, K.; Pawlak, and Michal M.( 2006). Hepcidin, Iron Status, and Renal Function in Chronic Renal Failure, Kidney Transplantation, and Hemodialysis. American Journal of Hematology 81:832–837.
Klahr, S .; Miller, S. (1998). "Acute oliguria ". N Engl J Med. , 338 :671-5.
Krause, A.; Neitz, S.; Magert, H.J. (2000). LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett. , 480: 147-50.
Krause, A.; Neitz, S.; Magert, H.J. (2000). LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett. , 480: 147-50.
Kroot ,J.J.; Tjalsma, H.; Fleming ,R.E. (2011) . Hepcidin in human iron disorders: diagnostic implications. Clin Chem., 57: 1650-1669.
Kuragano, T.; Shimonaka, Y.; Kida, A. (2010) . Determinants of hepcidin in patients on maintenance hemodialysis: role of inflammation. AmJNephrol., 31: 534-540.
Levy, J.; Morgan, J.; and Brown, E. (2005) .Oxford Handbook of Dialysis ,2nd ed . Oxford Univercity press ,UK.
Meyer, T.W. & Hostetter, T.H.(2007). Uremea .N. Engl. J. med., 357(13):1316-1325.
NIDDK (National Institute of Diabetes and Digestive and Kidney Disease) (2007). Pyelonephritis (Kidney Infection) in adult .NIH, U.S Department of Health and Human Services, online Publication at www.Kidney .niddk .nih gov.
Nolan, C.R.; Anderson, R.J. (1998). Hospital-acquired acute renal failure .Jam Soc Nephrol .,9: 710-12.
Park, C.H.;Valore, E.V.; Waring, A.J.; Ganz ,T.( 2001). Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem. ,276: 7806-7810.
Peslova, G.; Petrak, J.; Kuzelova, K. (2009) . Hepcidin, the hormone of iron metabolism, is bound specifically to alpha-2-macroglobulin in blood. Blood., 113: 6225-6236.
Peters, H.P.E.; Laarakkers, C.M.M.; Swinkels, D.W. (2010) .Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular "ltration rate. NephrolDialTransplant., 25: 848-853.
Pigeon, C.; Ilyin, G.; Courselaud, B. A. (2001) .New mouse liver-speci"c gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem. , 276: 7811-7819.
Premkumar, K. (2004). The massage connection: anatomy &physiology. 2nd Ed; Lippincott Williams & Wilkins, Philadelphia, USA
Ravera, M. R .e.M.; Deferrari, L.; vettoretti, S.; and Deferrari, G. (2006). Importance of blood pressure control in chronic Kidney disease on Hemodialysis . Experientia., 31:980-981.
Rusul ,A.A.A. AL-Hisnawi and Haider, s.(2014). A study of some biochemical changes in patients with chronic renal failure undergoing hemodialysis. Int.J.Curr.Microbiol.App.Sci . 3(5): 581-586
Salvador Lopez-Giacoman, Magdalena Madero.(2014). Biomarkers in chronic kidney disease, from kidney function to kidney damage. World J Nephrol .6; 4(1): 57-73.
Schrier, E.S. (2007). The principles of estimation of creatinine. Dtsch. Med. Wschr., 89: 1018, 1640.
Thadhani, R.;Pascual, M.; Bonventre, J.V. (1996) . Acute renal failure . N Engl J Med ., 334:1448-60.
Tomas& Ganz. (2003). Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood ., 102:783-788
Uchinos, M. (2005). Acute renal failure in critically ill patients :amultinational , multicenter study. JAMA; 204:813-18
Vijayakumar, M.; Nammalwar, B.and Prahlad, N. ( 2007). Prevention of chronic kidney disease in children. Indian journal of nephrology., 17:47-52.
Weinstein, D.A.;Roy, C.N.; Fleming, M.D.( 2002). Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood. ,100: 3776-3781.
Weiss, G. and Goodnough, L.T. (2005). Anemia of chronic disease. N Engl J Med., 352: 1011–23.
Yazar, H .and Kayhan. (2010). Adult Hemodialysis Patients with End-stage Renal Disease and Erythropoietin Treatment of the Relation between Hypertension. J Chem Pharm Res., 2: 588-93.
Zaritsky, J.; Young, B.; Wang ,H.J. (2009) .Hepcidin a potential novel biomarker for iron status in chronic kidney disease. ClinJAmSocNephrol . , 4: 1051-1056.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Dr. Rusul Arif Abd Ali
This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
